Reference
Johnson C, et al. Diagnosis and Management of Immune Checkpoint Inhibitor-related Toxicities in Ovarian Cancer: A Series of Case Vignettes. Clinical Therapeutics 40: 389-394, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1016/j.clinthera.2018.02.011 - USA
Rights and permissions
About this article
Cite this article
Ipilimumab/nivolumab/pembrolizumab. Reactions Weekly 1697, 212 (2018). https://doi.org/10.1007/s40278-018-44768-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44768-x